Figure 1From: An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents Chemotherapy guidelines for patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Back to article page